Trexquant Investment’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-72,223
Closed -$586K – 2161
2026
Q2
$586K Buy
+72,223
New +$529K ﹤0.01% 1601
2024
Q3
– Sell
-32,668
Closed -$106K – 1790
2024
Q2
$106K Buy
32,668
+469
+1% +$2.06K ﹤0.01% 1470
2024
Q1
$171K Buy
+32,199
New +$173K ﹤0.01% 1370
2021
Q4
– Sell
-27,735
Closed -$194K – 1550
2021
Q3
$194K Sell
27,735
-3,795
-12% -$28.4K 0.02% 963
2021
Q2
$289K Buy
+31,530
New +$319K 0.02% 735
2020
Q4
– Sell
-13,441
Closed -$136K – 1378
2020
Q3
$136K Buy
+13,441
New +$137K 0.01% 1127
2020
Q2
– Sell
-79,050
Closed -$667K – 1390
2020
Q1
$667K Buy
79,050
+48,863
+162% +$475K 0.05% 556
2019
Q4
$264K Sell
30,187
-18,319
-38% -$152K 0.02% 799
2019
Q3
$522K Buy
+48,506
New +$524K 0.05% 443
2019
Q2
– Sell
-65,430
Closed -$2.54M – 1043
2019
Q1
$2.54M Buy
+65,430
New +$2M 0.18% 164
2018
Q4
– Sell
-24,529
Closed -$1.12M – 1249
2018
Q3
$1.12M Buy
+24,529
New +$1.18M 0.08% 332
2018
Q2
– Sell
-9,281
Closed -$632K – 1127
2018
Q1
$632K Buy
+9,281
New +$695K 0.04% 555
2017
Q3
– Sell
-2,900
Closed -$253K – 968
2017
Q2
$253K Buy
+2,900
New +$162K 0.07% 550
2017
Q1
– Sell
-19,326
Closed -$593K – 1257
2016
Q4
$593K Buy
19,326
+2,897
+18% +$125K 0.09% 367
2016
Q3
$1.1M Buy
+16,429
New +$831K 0.25% 115
2016
Q2
– Sell
-32,600
Closed -$957K – 1035
2016
Q1
$957K Buy
+32,600
New +$1.47M 0.11% 312
2015
Q4
– Sell
-16,900
Closed -$1.27M – 1210
2015
Q3
$1.27M Buy
16,900
+14,500
+604% +$1.37M 0.11% 322
2015
Q2
$279K Buy
+2,400
New +$435K 0.03% 838

Other funds holding PBYI

Trexquant Investment's PBYI Position: Q3 2026 in Review

Trexquant Investment sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 72,223 shares — an estimated $586K sold.

Trexquant Investment first reported a position in PBYI in Q2 2015 and held it in 18 quarters. The position peaked at $2.54M in Q1 2019. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Trexquant Investment reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
  • Trexquant Investment sold 72,223 Puma Biotechnology shares in Q3 2026, an estimated $586K.
  • Trexquant Investment first reported a position in Puma Biotechnology in Q2 2015 and held it in 18 quarters.
  • Trexquant Investment's Puma Biotechnology position peaked at $2.54M in Q1 2019.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.